UNSPSC 51283902: Mafenide

This classification denotes an anti-infective agent with the molecular formula C7H10N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58447S8P4L, chemically known as p-toluenesulfonamide, .alpha.-amino-, monohydrochloride but generally known as mafenide, which bears US NIH Compound Identifier 3998. European Medicines Agency schedules Mafenide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08633MIG.

UNSPSC 51283902 Mafenide is a Commodity code for a specific pharmaceutical product, but recent state and local solicitations tagged under this code actually seek procurement of a broader range of pharmaceutical and medical products—naloxone, drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies—rather than mafenide itself. State and local buyers are using this code to solicit pharmaceuticals and medical consumables for public health, emergency response, and pharmacy benefit programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), city fire and rescue divisions (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). Most recent opportunities show activity from health departments, emergency services, and state pharmacy programs seeking either direct product supply or vendor capability information to support broader pharmaceutical access initiatives.

Geographic activity centers on Florida, Texas, and Minnesota as of the most recent postings. Representative solicitations include Seminole County's IFB60459723LAS (posted June 30, 2026; due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county health building; the City of Tampa's 26P00145 IFB (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000 and a small local business enterprise set-aside; and MMCAP's S1070000015802 RFP (posted January 20, 2026; due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon. The Texas HHS RFI (posted April 3, 2026) on direct-to-manufacturer prescriptions reflects exploratory procurement strategy rather than a formal supply solicitation.